Allspring Global Investments Holdings LLC Grows Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Allspring Global Investments Holdings LLC lifted its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 3.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,624,501 shares of the company’s stock after purchasing an additional 49,331 shares during the quarter. Allspring Global Investments Holdings LLC owned 3.29% of Prestige Consumer Healthcare worth $126,274,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the stock. SG Americas Securities LLC bought a new stake in Prestige Consumer Healthcare during the third quarter valued at approximately $364,000. GAMMA Investing LLC lifted its holdings in shares of Prestige Consumer Healthcare by 49.9% during the 3rd quarter. GAMMA Investing LLC now owns 1,163 shares of the company’s stock worth $84,000 after acquiring an additional 387 shares during the last quarter. Inspire Investing LLC grew its position in Prestige Consumer Healthcare by 11.7% in the third quarter. Inspire Investing LLC now owns 5,702 shares of the company’s stock worth $411,000 after acquiring an additional 599 shares in the last quarter. Exchange Traded Concepts LLC increased its stake in Prestige Consumer Healthcare by 6.3% in the third quarter. Exchange Traded Concepts LLC now owns 22,801 shares of the company’s stock valued at $1,644,000 after acquiring an additional 1,343 shares during the last quarter. Finally, Creative Planning raised its position in Prestige Consumer Healthcare by 32.6% during the third quarter. Creative Planning now owns 10,011 shares of the company’s stock valued at $722,000 after purchasing an additional 2,460 shares in the last quarter. 99.95% of the stock is currently owned by institutional investors.

Prestige Consumer Healthcare Price Performance

PBH opened at $86.03 on Wednesday. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.10. The stock’s 50 day simple moving average is $79.28 and its 200 day simple moving average is $75.63. The firm has a market cap of $4.25 billion, a price-to-earnings ratio of 20.15, a PEG ratio of 2.43 and a beta of 0.50. Prestige Consumer Healthcare Inc. has a 1 year low of $62.35 and a 1 year high of $88.36.

Prestige Consumer Healthcare (NYSE:PBH) last issued its earnings results on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. As a group, analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on PBH. Sidoti cut Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective for the company. in a report on Monday, December 9th. Canaccord Genuity Group boosted their target price on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. StockNews.com upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, January 24th. DA Davidson boosted their price objective on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a “buy” rating in a report on Friday, February 7th. Finally, Raymond James raised shares of Prestige Consumer Healthcare to a “moderate buy” rating in a report on Thursday, December 19th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $92.50.

Insiders Place Their Bets

In other Prestige Consumer Healthcare news, CEO Ronald M. Lombardi sold 10,875 shares of the stock in a transaction that occurred on Tuesday, November 19th. The stock was sold at an average price of $82.60, for a total value of $898,275.00. Following the completion of the sale, the chief executive officer now owns 320,952 shares in the company, valued at approximately $26,510,635.20. This trade represents a 3.28 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 1.60% of the company’s stock.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.